1. Introduction

Atrial fibrillation is a supraventricular arrhythmia characterized by disorganized atrial electrical activation, loss of coordinated atrial contraction, and irregular atrioventricular conduction. On the ECG, the classic pattern is an irregularly irregular ventricular rhythm without consistent discrete P waves.

AF is clinically important because it may cause palpitations, dyspnoea, fatigue, syncope or haemodynamic compromise, and is associated with heart failure, tachycardia-mediated cardiomyopathy and systemic thromboembolism, particularly ischaemic stroke.

2. Electrophysiology and Pathophysiology

AF generally requires both a trigger that initiates the arrhythmia and an atrial substrate capable of sustaining it. Ectopic atrial activity, often arising from myocardial sleeves extending into the pulmonary veins, can initiate AF. Atrial dilatation, fibrosis, inflammation and electrical remodelling can facilitate its persistence.

Mechanisms described in the supplied reference

• Focal activation: rapid ectopic activity from a focal source, commonly near the pulmonary veins, may result from enhanced automaticity or localized re-entry.
• Multiple-wavelet mechanism: multiple small, wandering re-entrant wavefronts propagate through atrial tissue. A larger or structurally remodelled atrium can provide a more favourable substrate for their persistence.

Because atrial activation is chaotic, there is no single organized atrial depolarization corresponding to each QRS complex. The AV node receives a continuously changing barrage of impulses and conducts only a variable proportion of them, producing irregular R–R intervals.

3. Characteristic ECG Features

Ventricular rate patterns

• AF with rapid ventricular response: an irregular tachycardia. The supplied reference labels a ventricular rate above 100 bpm as rapid response and illustrates a narrow-complex example at approximately 135 bpm.
• AF with controlled ventricular response: the ventricular rate is not markedly fast or slow; the irregular rhythm and absent organized P waves remain the diagnostic clues.
• AF with slow ventricular response: an irregular rhythm with a slow ventricular rate. Consider AV-nodal blocking medication, digoxin effect or toxicity, hypothermia, conduction disease and other causes of impaired AV conduction.

Fibrillatory waves may be coarse (larger amplitude) or fine (small amplitude), and may be most apparent in V1 or the inferior leads. Their absence on a particular lead does not exclude AF.

4. Systematic ECG Interpretation

Use a consistent sequence. Confirm the rhythm before assigning a rate-related label or interpreting secondary ST–T changes.

5. Diagnostic Criteria

The diagnosis is based on ECG documentation of disorganized atrial activity and an irregular ventricular response in the absence of consistent organized P waves. No single ventricular-rate threshold is required.

For clinical AF, the 2024 ESC guideline requires confirmation using an ECG-capable device before initiating AF risk stratification and management. A standard 12-lead ECG provides a 10-second recording; at least 30 seconds on single- or multiple-lead ECG monitoring has commonly been used as a consensus threshold, although the evidence for a fixed duration is limited. Interpret the tracing in its clinical and technical context.

6. Differential Diagnosis

7. Wide Complexes During AF: Ashman Phenomenon

Ashman phenomenon is rate-related aberrant ventricular conduction during an irregular supraventricular rhythm, classically AF. A relatively long R–R interval followed by a shorter interval can leave part of the His–Purkinje system refractory when the next impulse arrives, producing a transient wide QRS, commonly with right bundle branch block morphology.

Do not assume every wide beat during AF is Ashman phenomenon. Consider ventricular premature beats, ventricular tachycardia, pre-existing bundle branch block, pacing and pre-excitation. Evaluate the sequence, morphology, clinical state and prior ECGs.

8. Critical Pattern: AF with Pre-excitation (WPW)

AF in a patient with an accessory pathway can conduct rapidly to the ventricles outside the protective filtering effect of the AV node. This can produce very rapid, irregular, wide QRS complexes with beat-to-beat variation in morphology and may deteriorate into ventricular fibrillation.

Management principle

• Haemodynamic instability: immediate synchronized electrical cardioversion.
• Stable pre-excited AF: guideline-supported options include IV procainamide or ibutilide, with urgent specialist involvement; electrical cardioversion may be preferred depending on the clinical situation.
• Avoid AV-nodal blocking agents in pre-excited AF, including adenosine, beta-blockers, verapamil, diltiazem and digoxin; these can favour accessory-pathway conduction and precipitate ventricular fibrillation. Amiodarone is also not recommended in this setting by the 2023 ACC/AHA/ACCP/HRS guideline.
• Definitive management commonly includes electrophysiology assessment and accessory-pathway catheter ablation.

9. Clinical Significance and Initial Evaluation

The ECG establishes the rhythm, but it does not by itself determine the cause, thromboembolic risk or complete treatment plan. New AF warrants clinical assessment for symptoms, haemodynamic status, duration/pattern, precipitating conditions and comorbidities.

Potential complications

• Systemic thromboembolism and ischaemic stroke associated with atrial/left atrial appendage stasis and thrombus formation.
• Heart failure or worsening of pre-existing ventricular dysfunction.
• Tachycardia-mediated cardiomyopathy with sustained rapid ventricular rates.
• Syncope, hypotension or shock in patients with compromised haemodynamics.

Initial evaluation principles

• Assess blood pressure, perfusion, oxygenation, symptoms, chest pain, pulmonary oedema and signs of shock.
• Review prior ECGs, medication exposure (including AV-nodal blockers and digoxin), alcohol and stimulant use, and possible acute triggers.
• Consider blood count, renal and liver function, electrolytes, glucose and thyroid function according to the clinical setting.
• Use echocardiography when it will guide management or when structural disease is suspected; consider ambulatory ECG monitoring to assess AF burden and ventricular rate.
• Assess stroke and bleeding risk using current guideline-supported approaches; reassess risk over time.

10. Common Interpretation Pitfalls

• Calling AF solely because the rhythm is irregular: actively look for P waves and consider MAT, frequent PACs and sinus arrhythmia.
• Requiring visible fibrillatory waves: fine AF may have low-amplitude baseline activity that is difficult to appreciate.
• Assuming AF must be tachycardic: slow AF occurs, including with AV-nodal drugs, digoxin effect/toxicity, hypothermia or conduction disease.
• Misreading artifact as fibrillatory activity: compare multiple leads, check whether QRS complexes remain regular underneath the artifact, and correlate with the pulse.
• Misclassifying Ashman beats as ventricular ectopy: assess the preceding long–short R–R sequence and typical aberrant morphology.
• Missing pre-excited AF: a very rapid irregular wide-complex rhythm with variable QRS morphology is an emergency pattern; do not give AV-nodal blockers when pre-excited AF is suspected.
• Attributing ST–T changes automatically to AF: consider ischaemia, rate-related changes, electrolyte abnormalities and medication effects such as digoxin.

11. ECG Interpretation Practice

Use these short questions to reinforce pattern recognition. The examples below refer to authentic tracings in the supplied PDF; the clinical scenarios and measurements are not expanded beyond what the source states.

12. Clinical Pearls and Red Flags

Clinical pearls

• The most useful pattern is irregularly irregular R–R intervals with no consistent P waves.
• V1 and lead II are often useful for examining atrial activity, but inspect all leads.
• Fine fibrillatory waves can be subtle; the absence of obvious f-waves does not rule out AF.
• QRS complexes are usually narrow unless another conduction or activation abnormality is present.
• AF diagnosis and stroke prevention decisions are separate steps: the ECG pattern does not quantify embolic risk.

Red flags

• Hypotension, shock, ongoing ischaemic chest pain, acute pulmonary oedema, syncope or altered mental status.
• Very rapid irregular wide-complex rhythm with variable QRS morphology — suspect pre-excited AF.
• Marked bradycardia or pauses with symptoms — evaluate for drug effect or significant conduction-system disease.
• New focal neurological deficit or suspected systemic embolism.

13. Quick Reference Summary

14. References